Intellectual Property and the Valuation of Biotechnology Companies: Gen-Dex Versus Dow Jones

11 Pages Posted: 6 Aug 1997

See all articles by Elli Malki

Elli Malki

Financial-Tip; Rothberg International School of the HU - MA in Nonprofit Management and Leadership; Hebrew University - M.A. in Management of Nonprofit and Community Organizations

Abstract

The role of intellectual property (IP) as an important value determinant is widely recognized. This article tries to quantify the role of IP in companies valuation by comparing a sample of biotechnology companies (46 companies included in the Genetic Engineering New Index: GEN-dex) to the companies included in the Dow Jones Index. Conventional wisdom suggests that the biotechnology sector will derive more significant portion of its value from IP. The article proposes a measure for the significance of IP in the determination of value, which is named the IP Intensity. Comparing the distribution of IP Intensity in the two samples demonstrates that this measure is a useful tool for the analysis of value determination.

JEL Classification: G12, G14

Suggested Citation

Malki, Elli, Intellectual Property and the Valuation of Biotechnology Companies: Gen-Dex Versus Dow Jones. Available at SSRN: https://ssrn.com/abstract=43181 or http://dx.doi.org/10.2139/ssrn.43181

Elli Malki (Contact Author)

Financial-Tip ( email )

P.O.B. 44034
Jerusalem, 91440
Israel
972-2-6568906 (Phone)

HOME PAGE: http://www.financial-tip.co.il

Rothberg International School of the HU - MA in Nonprofit Management and Leadership ( email )

Boyar Building, Mt. Scoupus
Jerusalem, 91905
Israel
026568906 (Phone)

HOME PAGE: http://www.financial-tip.co.il

Hebrew University - M.A. in Management of Nonprofit and Community Organizations ( email )

Jerusalem
Israel
97226568906 (Phone)

HOME PAGE: http://www.financial-tip.co.il

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
732
Abstract Views
3,555
rank
41,336
PlumX Metrics